Page last updated: 2024-08-23

tetradecanoylphorbol acetate and Critical Illness

tetradecanoylphorbol acetate has been researched along with Critical Illness in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duan, C; Li, T; Liu, L; Yang, G1

Reviews

1 review(s) available for tetradecanoylphorbol acetate and Critical Illness

ArticleYear
Advances in Vascular Hyporeactivity After Shock: The Mechanisms and Managements.
    Shock (Augusta, Ga.), 2015, Volume: 44, Issue:6

    Topics: Acidosis; Adult; Age Factors; Aged; Analgesics, Opioid; Blood Vessels; Burns; Calcium; Carbon Monoxide; Cell Membrane; Critical Illness; Endothelins; Female; Humans; Male; Middle Aged; Nitric Oxide; Peptides; Protein Kinase C; rho-Associated Kinases; Sex Factors; Shock, Hemorrhagic; Shock, Septic; Tetradecanoylphorbol Acetate; Vasoconstrictor Agents; Vasodilator Agents

2015